Revenue

A French biopharma's leap in synthetic lipid production de-risks its lead drug, eyes a vast sepsis market, and creates new commercial avenues.

The Lynx M20, a Chinese wheeled-legged robot, nabs a prestigious iF Design Award, showcasing a blend of rugged function and advanced engineering.

The SFC-licensed platform now offers the most compliant tokenized securities in Hong Kong, bridging institutional capital with on-chain finance.

The pharma giant's acquisition of Excellergy and its first-in-class Exl-111 could revolutionize treatment for millions with severe, debilitating allergies.

At the Boao Forum, UnionPay unveiled a bold strategy to reshape cross-border payments, focusing on the Global South, AI, and local currency settlements.

North America's first 24/7 Japanese food channel, Channel Oishii, launches on Amasian TV, bringing the flavors and stories of Japan to viewers for free.

Trooly.AI's new platform uses AI agents to conduct 45-minute user interviews, but its 'Empathy Engine' raises new questions about tech and ethics.

From Taiwan to the world, Gogoro's battery swapping network is reshaping urban transport. Can its proven model solve Asia's mobility and pollution woes?

A new AI app promises to fix flawed photos after you've taken them, blurring the line between capturing a moment and recreating it from memory.

From a $20k loan to a major wellness player, a women-founded brand proves sustainability and science are the future of sleep and business.

Neapco's acquisition of IFA Group is complete, creating a global automotive driveline leader with nearly $2B in sales and a vast, integrated portfolio.

The digital infrastructure firm secured new funding for expansion, but a steep discount in its offering has rattled investors and sent its share price plunging.

Motorola Solutions' major acquisition of Bell's radio network business signals a strategic shift for both giants and impacts Canada's first responders.

Firan Technology Group sets its Q1 earnings date. With a record 2025 behind it, all eyes are on whether it can sustain growth amid industry trends.

After a year of strategic shifts, Nortech Systems reports a strong Q4, signaling its restructuring efforts and nearshoring focus are finally paying off.

Agenus prepares a crucial update on its BOT+BAL immunotherapy, a potential breakthrough for cancers resistant to current treatments. What will they reveal?

INNOVATE Corp. reports a 62% Q4 revenue surge, but a 'going concern' warning and looming debt have forced the company to explore selling key assets.

Shareholders approve the CVB Financial and Heritage Commerce merger, forging a $22B regional bank. What does this mean for California's financial landscape?

Crinetics Pharmaceuticals aims to disrupt Brazil's acromegaly treatment with Palsonify, a once-daily pill challenging the standard of monthly injections.

As outdoor recreation booms and volunteer support wanes, a tech and auto partnership is scaling up efforts to restore threatened public land trails.